Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Rapid Versus Slow Entral Feeding Advancements on Clinical Outcomes of Preterm Infants (pretermfood)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03214744
Recruitment Status : Not yet recruiting
First Posted : July 12, 2017
Last Update Posted : July 17, 2017
Sponsor:
Information provided by (Responsible Party):
Amany Makrm Riad, Assiut University

Brief Summary:
Rapid Versus Slow Entral Feeding Advancements on Clinical Outcomes of Preterm Infants

Condition or disease
Preterm Infant

Detailed Description:
Rapid feeding advancement achieves full enteral volume of feedings earlier than the slower advancement.They received significantly fewer days of parenteral nutrition, exhibited a shorter time to regain birth weight and shorter duration of hospital stay. The incidence of NEC and the number of episodes of feeding intolerance were not significantly different between rapid and slow advancement. while the incidence of culture-proven late onset sepsis was significantly less in infants receiving a rapid feeding advancement

Layout table for study information
Study Type : Observational
Estimated Enrollment : 1 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Rapid Versus Slow Entral Feeding Advancements on Clinical Outcomes of Preterm Infants
Estimated Study Start Date : May 2018
Estimated Primary Completion Date : December 2018
Estimated Study Completion Date : June 2019



Primary Outcome Measures :
  1. effect of entral feeding on preterm [ Time Frame: six months ]
    -Length of hospital stay.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 15 Weeks   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Neonates (<36 weeks)
Criteria

Inclusion Criteria:

- All preterm neonates admitted to NICU with gestational age less than 36 weeks, and haemodynamically stable

Exclusion Criteria:

  • gastrointestinal tract anomalies,
  • haemodynamically unstable infants,
  • gestatinal age equal or more than 36 weeks,
  • preterms who develop NEC,
  • preterms on mechanical ventilation.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03214744


Contacts
Layout table for location contacts
Contact: professor Mohamed Mahrous Sayed 01003486595 Eltellawy270@hotmail.com
Contact: Lecture Safwat Mohammed Abdel-Aziz 01003918080 Safwatabdaziz371@yahoo.com

Locations
Layout table for location information
Egypt
Assiut university
Assiut, Egypt, 71515
Sponsors and Collaborators
Assiut University
Investigators
Layout table for investigator information
Principal Investigator: John J Smith National Institutes of Health Clinical Center (CC)

Publications:
Layout table for additonal information
Responsible Party: Amany Makrm Riad, Rapid Versus Slow Entral Feeding Advancements on Clinical Outcomes of Preterm Infants, Assiut University
ClinicalTrials.gov Identifier: NCT03214744     History of Changes
Other Study ID Numbers: 17100036
First Posted: July 12, 2017    Key Record Dates
Last Update Posted: July 17, 2017
Last Verified: July 2017

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Premature Birth
Obstetric Labor, Premature
Obstetric Labor Complications
Pregnancy Complications